Insulin resistance as risk factor of cardiovascular diseases
https://doi.org/10.18705/2311-4495-2015-0-6-32-38
Abstract
The article presents the literature data on the prevalence and role of insulin resistance - hyperinsulinemia in the development of cardiovascular pathology. Found, that insulin resistance, as a syndrome not rarely encountered in internal medicine, is a pathophysiological base for the developing of some metabolic and hemodynamic changes, that can play significant role in pathogenesis of the arterial hypertension, CAD, diabetes mellitus and other atherosclerotic disease. Early diagnosis of the insulin resistance syndrome can help reduce the risk of cardiovascular complications.
About the Authors
L. A. Sokolova
Federal Almazov North-West Medical Research Centre
Russian Federation
Russian Federation
E. V. Ievskaia
Federal Almazov North-West Medical Research Centre
Russian Federation
Russian Federation
References
1. Moller D, Flier J. Insulin resistance - mechanisms, syndromes, and implications.// N Engl J Med 1991. - № 325 (13). - P. 938-48.
2. Bock G., Chittilapilly E., Basu R. et al. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose. Roleofincreasedrates of gluconeogenesis // Diabetes. 2007. - № 56. - P. 1703-1710.
3. Шестакова М.В., Брескина О.Ю. Инсулинорезистент-ность: патофизиология, клинические проявления, подходы к лечению // Consilium medicum, 2002. - № 10.
4. Muller-Wieland D, Taub R et al. Insulin-receptor gene and its expression in patients with insulin resistance.// Diabetes 1989. - № 38. - Р. 31-8.
5. Boller S, Joblin BA, Xu L et al. From signal transduction to signal interpretation: an alternative model for the molecular function of insulin receptor substrates. Arch Physiol Biochem 2012. - № 118. - Р. 148-155.
6. Accili D, Cama A, Barbetti F et al. Insulin resistance due to mutation of the insulin receptor gene: an overview.// J Endocrinol Invest 1992. - № 15. - Р. 857-64.
7. Boor R. Familiar insulin resistance diabetes associated with acantosis nigricans, policystic ovarian hypogonadism, pigmentary retinopathy, labyrinthine deafness and mental retardation.// J Am Med Genet 1993. - № 45 (5).
8. Bonora E., Kiechl S., Willeit J. et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.// Diabetes. 1998. - № 47. - Р. 1643-1649.
9. Geneose clamp technique: a method for quantifying insulin secretion and resistance / R. A. de Fronzo, J. D. Tobin, R. Andres // Am. J. Physiol. - 1979. - Vol. 237. - P. S214-S223.
10. Nestler J. E. Assesment of insulin resistance / J. E. Nestler // Sci. Med. - 1994. - Vol. 1. - P. 58-67.
11. Алмазов В.А., Благосклонная Я.В , Шляхто Е.В. и др. Синдром исулинорезистентности. // Артериальная гипертензия. - 1997. - № 3. - С. 7-17.
12. Insulin receptor deficiency in genetic and aequired obesity / H. A. Soll, C. R. Kahn, D. Ir. Neville et al. // J. Clin. Invest. - 1975. - Vol. 53. - P. 582-584.
13. Insulin resistance in essential hypertension / E. Ferrannini, G. Buzzigoli, R. Bonadonna et al. // N. Engl. J. Med. - 1987. - № 317. - P. 350-357.
14. Иевская Е.В., Соколова Л.А., Сердюков С.В. Поражение органов-мишеней у больных артериальной гипертензией с нормальной массой тела и инсулинорезистентностью // Кардиоваск. терапия и проф. - 2013. - №12. - С. 77-78.
15. Pollare T., Lithell H., Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity.// Metabolism. 1990 Feb. - № 39(2). - Р. 167-174.
16. Julius S., Jamerson K., Mejja A., Krause L., Schork N., Jones K. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study.// JAMA 1990. - № 264. - Р. 354-358.
17. Skarfors ET, Lithell HO, Selinus I. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men.// J Hypertens 1991. - № 9. - Р. 217-23.
18. Capaldo B., Lembo G., Napoli R, et al. Skeletal muscle is a primary site of insulin resistance in essential hypertension.// Metabolism 1991. - № 40. - Р. 1320-1322.
19. Nataly A., Santoro D., Palombo C. et al. Impared insulin action on skeletal muscle metabolism in essential hypertension. // Hypertension 1991. - № 17. - Р. 170-178.
20. Weidemann P., Bohlen L., de Courten M. Insulin resistance and hyperinsulinemia in hypertension.// J Hypertens 1995. - № 13 (2). - Р 65-72.
21. Lillioja S., Young A.A., Culter C.L. et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.// J Clin Invest 1987. - № 80 (415). - Р. 424.
22. Lithell H., Pollare T., Berne C., Saltin B. The metabolic and circulatory response to beta-blockade in hypertensive men is correlated to muscle capillary density.// Blood Pressure 1992. - № 1. - P 20-26.
23. Laakso M., Edelman S.V., Brechtel G., Baron A.D. Decreased effect of insulin to stimulate skeletal blood flow in obese men.// J Clin Invest 1990. - № 85. - Р. 1844-1852.
24. Lind L., Lithell H. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia.// Am Heart J 1993. - № 125. - Р. 1494-1497.
25. Landsberg L, Aronne LJ, Beilin LJ et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment. A position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich) 2013. - № 15. - Р. 14-33.
26. Ferrari P, Weidmann P. Insulin, insulin sensitivity and hypertension.// J Hypertens 1990. - № 8. - Р. 491-500.
27. Juhlin-Dannfeld A., Frisk-Holmberg F., Karlsson J., Tesch P. Central and peripheral circulation in relation to musclefiber composition in normo- and hypertensive man// Clin Sci 1979. - № 56. - Р. 335-340.
28. Harrison D. G. Endothelial function and oxidant stress // Clin. Cardial. - 1997. - Vol. 20. - P.11-17.
29. Reaven G.M. Role of insulin resistence in human disease: an expanded definition // Annual review of Medicine. - 1993. - Vol. 44. - P. 121-131.
30. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S. Insulin resistance, hyperinsulinemia and blood pressure. Role of age and obesity.// Hypertension 1997. - № 30. - Р. 1144-9.
31. Иевская Е.В., Соколова Л. А. Оценка влияния инсулинорезистентности на течение артериальной гипертензии у больных гипертонической болезнью с нормальной массой тела. // Материалы Российского национального Конгресса кардиологов «Кардиология 2013: от науки к практике» 23-27.09.2013 г. - С. 479-480.
32. Stout R. W. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease / R. W. Stout // Am. J. Med. - 1991. - Vol. 90. - P. 62S-65S.
33. Involvment of the Haemostatic System in the Insulin Resistance Syndrom. A Study of 1500 Patients with Angina Pectoris / J. Juhanvague, S. J. Thompson, J. Jesoersen // Artherioscler Tromb. - 1993. - № 12. - P. 1865-1873.
34. Профилактика сердечно-сосудистых заболеваний в клинической практике. Рекомендации Европейского общества кардиологов (пересмотр 2012 г.) // Российский кардиологический журнал. - 2012. - № 4 (96), Приложение 2.
Review
For citations:
Sokolova L.A., Ievskaia E.V. Insulin resistance as risk factor of cardiovascular diseases. Translational Medicine. 2015;(6):32-38. (In Russ.) https://doi.org/10.18705/2311-4495-2015-0-6-32-38
Views:
852
Email this article 